These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Response to Julio Pascual regarding Kishore-Kumar et al. (Pain, 37 (1989) 223-227). Max MB; Kishore-Kumar R; Lawlor BA; Murphy DL Pain; 1990 Jan; 40(1):117. PubMed ID: 2339010 [No Abstract] [Full Text] [Related]
3. Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Kishore-Kumar R; Schafer SC; Lawlor BA; Murphy DL; Max MB Pain; 1989 May; 37(2):223-227. PubMed ID: 2664664 [TBL] [Abstract][Full Text] [Related]
4. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. Alhaider AA; Wilcox GL J Pharmacol Exp Ther; 1993 Apr; 265(1):378-85. PubMed ID: 7682614 [TBL] [Abstract][Full Text] [Related]
5. Serotonin in pain and analgesia: actions in the periphery. Sommer C Mol Neurobiol; 2004 Oct; 30(2):117-25. PubMed ID: 15475622 [TBL] [Abstract][Full Text] [Related]
6. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation. Blier P; Seletti B; Gilbert F; Young SN; Benkelfat C Neuropsychopharmacology; 2002 Aug; 27(2):301-8. PubMed ID: 12093604 [TBL] [Abstract][Full Text] [Related]
7. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Landén M; Eriksson O; Sundblad C; Andersch B; Naessén T; Eriksson E Psychopharmacology (Berl); 2001 May; 155(3):292-8. PubMed ID: 11432692 [TBL] [Abstract][Full Text] [Related]
9. Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System. Cortes-Altamirano JL; Olmos-Hernandez A; Jaime HB; Carrillo-Mora P; Bandala C; Reyes-Long S; Alfaro-Rodríguez A Curr Neuropharmacol; 2018 Jan; 16(2):210-221. PubMed ID: 28901281 [TBL] [Abstract][Full Text] [Related]
11. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. Fuller RW; Perry KW J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors. Fuller RW; Mason NR Adv Exp Med Biol; 1981; 133():359-68. PubMed ID: 6172017 [No Abstract] [Full Text] [Related]
14. Serotonin receptor responsivity in schizophrenia. Kahn RS; Davidson M Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():47-51. PubMed ID: 7911140 [No Abstract] [Full Text] [Related]
15. Serotonin syndrome from fluvoxamine and buspirone. Baetz M; Malcolm D Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727 [No Abstract] [Full Text] [Related]
16. Activation of spinal serotonin(2A/2C) receptors augments nociceptive responses in the rat. Kjørsvik A; Tjølsen A; Hole K Brain Res; 2001 Aug; 910(1-2):179-81. PubMed ID: 11489268 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of putative neurotransmitters and receptors: 5-hydroxytryptamine. Roberts MH Prog Brain Res; 1988; 77():329-38. PubMed ID: 3064175 [No Abstract] [Full Text] [Related]
19. The new generation of serotonergic anxiolytics: possible clinical roles. Eison MS Psychopathology; 1989; 22 Suppl 1():13-20. PubMed ID: 2567037 [TBL] [Abstract][Full Text] [Related]
20. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover. Ballarín M; Carceller A; Guitart X Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]